https://www.indianpharmapost.com/revvity-posts-higher-q4-earnings-lifts-2026-outlook-as-diagnostics-strength-offsets-margin-pressure-190432026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-fdas-tentative-approval-for-dapagliflozin-tablets-190442026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-launches-topiramate-er-capsules-in-us-190452026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/strides-pharma-inc-receives-usfda-closure-report-for-chestnut-ridge-formulations-facility-190462026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-weathers-pricing-pressure-bets-big-on-oral-wegovy-190472026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-posts-higher-revenue-in-2025-led-by-immunology-neuroscience-growth-190482026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/eli-lilly-posts-blockbuster-q4-2025-results-issues-bullish-2026-outlook-190492026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-daiichi-sankyo-gain-priority-review-for-datroway-in-hard-to-treat-breast-cancer-190512026-02-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-reviews-astrazenecas-saphnelo-for-subcutaneous-use-in-lupus-190522026-02-05T00:00:00+05:30always0.9